Apollomics Faces Nasdaq Delisting
Ticker: APLMW · Form: 6-K · Filed: Sep 25, 2025 · CIK: 1944885
| Field | Detail |
|---|---|
| Company | Apollomics Inc. (APLMW) |
| Form Type | 6-K |
| Filed Date | Sep 25, 2025 |
| Risk Level | high |
| Pages | 2 |
| Reading Time | 2 min |
| Sentiment | bearish |
Sentiment: bearish
Topics: delisting, compliance, sec-filing
Related Tickers: APLO
TL;DR
Nasdaq's gonna delist Apollomics unless they fight it. Big trouble.
AI Summary
Apollomics Inc. received a delisting notice from Nasdaq on September 22, 2025, stating that its securities will be delisted unless the company requests an appeal. This action follows a failure to meet Nasdaq's continued listing requirements.
Why It Matters
A Nasdaq delisting can significantly reduce liquidity and investor confidence, potentially impacting the company's ability to raise capital and its stock valuation.
Risk Assessment
Risk Level: high — The company is facing delisting from a major stock exchange, which poses a significant threat to its market presence and financial stability.
Key Players & Entities
- Apollomics Inc. (company) — The company receiving the delisting notice.
- Nasdaq (company) — The stock exchange issuing the delisting notice.
- September 22, 2025 (date) — Date Apollomics received the delisting notice.
FAQ
What is the specific reason Nasdaq provided for the potential delisting of Apollomics Inc. securities?
The filing states that the delisting is due to failure to meet Nasdaq's "continued listing requirements."
What is the deadline for Apollomics Inc. to request an appeal against the delisting notice?
The filing does not specify a deadline for requesting an appeal, only that Nasdaq will delist the securities "unless the Company requests an appeal."
What is the ticker symbol for Apollomics Inc. on Nasdaq?
The filing does not explicitly state the ticker symbol, but it is implied to be listed on Nasdaq.
What are the consequences if Apollomics Inc. does not appeal the delisting notice?
If Apollomics Inc. does not request an appeal, Nasdaq will proceed with delisting the company's securities.
Does the filing indicate any specific steps Apollomics Inc. plans to take in response to the delisting notice?
The filing states that the company received the letter and that Nasdaq will delist unless an appeal is requested, but it does not detail Apollomics' specific response plans.
Filing Stats: 456 words · 2 min read · ~2 pages · Grade level 12.2 · Accepted 2025-09-25 17:01:38
Filing Documents
- d58766d6k.htm (6-K) — 14KB
- d58766dex991.htm (EX-99.1) — 14KB
- d58766dex992.htm (EX-99.2) — 8KB
- g58766g0925214525433.jpg (GRAPHIC) — 4KB
- 0001193125-25-217820.txt ( ) — 42KB
From the Filing
Form 6-K OMB APPROVAL OMB Number: 3235-0116 Expires: December 31, 2026 Estimated average burden hours per response 8.7 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of September, 2025. Commission File Number 001-41670 Apollomics, Inc. (Translation of registrant's name into English) 989 E. Hillsdale Blvd., Suite 220, Foster City, California 94404 (Address of principal executive office) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-FForm 40-F Press Releases On September 22, 2025, Apollomics Inc. ("Apollomics" or the "Company") issued a press release announcing its receipt of a letter from the Listing Qualifications Staff (the "Staff") of The Nasdaq Stock Market, LLC ("Nasdaq") indicating that unless the Company requests an appeal, Nasdaq will delist the Company's securities under Nasdaq Listing Rule 5101 based on the Staff's belief that Apollomics is now only a "public shell". As discussed in greater detail in the press release, the Company disagrees with the Staff and will appeal. The press release also provides certain updates with respect to the Company's ongoing operations. On September 25, 2025, Apollomics issued another press release announcing its completion of the filing of its application on September 23, 2025 to appeal the delisting notification it had earlier received from the Staff of Nasdaq. Additionally, Apollomics announced that in connection with the Writ and Statement of Claim issued in the Grand Court of the Cayman Islands by one investment manager for two minority investors in the Company dated July 22, 2024 (the "Cayman Litigation"), the Grand Court of the Cayman Islands has issued a consent order via consent of all parties that all further steps in these proceedings of the Cayman Litigation are stayed from and after September 12, 2025, until further order from such court. The press releases are attached here as Exhibit 99.1 and 99.2. EXHIBITS Exhibit No. Description 99.1 Press Release - Apollomics Announces Receipt of Delisting Determination Letter from Nasdaq 99.2 Press Release - Apollomics Announces Completion of Filing of Appeal of Nasdaq Delisting Order SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. /s/ Peter Lin Date September 25, 2025 (Signature) * Peter Lin, Chief Financial Officer * Print the name and title under the signature of the signing officer. SEC 1815 (07-22) Potential persons who are to respond to the collection of information contained in this Form are not required to respond unless the Form displays a currently valid OMB control number.